Libby Baney was interviewed by Informa Pharma Intelligence for a story about the U.S. Food and Drug Administration (FDA)’s recent report to Congress on the lawful use of cannabidiol (CBD) in food and dietary supplements.
“The report left many searching for more guidance from the agency on what comes next as it does not offer any recommendations around the future of the agency’s oversight of the CBD industry. In so many words, the FDA told Congress: ‘We’re working on it; please stay tuned.'" libby baney
Baney added that while the FDA has noted some concerns in connection with CBD, further testing and evaluation are needed, as it would help the industry cooperate with mandates more efficiently.